Early findings show new drug could be ‘gamechanging’ for brain cancer treatment
Using ipatasertib, researchers say some brain cancers could potentially be made vulnerable to immunotherapy agentTwo people with advanced brain cancer of the sort that led to the death of the MP Tessa Jowell have responded well in a small trial to an experimental combination of chemo and immunotherapy drugs. In one case, the life-threatening tumour seems to have disappeared.Doctors at the Institute of Cancer Research and the Royal Marsden hospital in London cautioned that this was very early research but said it was unusual to have such a good response in patients in an early trial.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 11, 2021 Category: Science Authors: Sarah Boseley Tags: Cancer research Medical research Health Science Society Source Type: news

Hopes of a cure for brain cancer that killed former Labour MP Tessa Jowell
A British father-of-two is one of ten patients with advanced glioblastoma brain cancer - the disease that killed Tessa Jowell - on a new combination treatment which is in early trial stages. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2021 Category: Consumer Health News Source Type: news

Light shed on the coordination of neural stem cell activation
(Institut Pasteur) Scientists at the Institut Pasteur, CNRS, and Tel Aviv University working in collaboration with the É cole Polytechnique and INRAE have successfully performed 3D visualization and spatial and temporal distribution analysis of neural stem cell activation in the adult brain of a zebrafish vertebrate model.Their findings demonstrate for the first time that activation events for these cells are coordinated in time and space. In particular, these results may help improve our understanding of regulation processes triggered during brain tumor formation. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 8, 2021 Category: Biology Source Type: news

A new treatment for metastatic lung cancer
(University of Colorado Anschutz Medical Campus) A new phase 3 randomized clinical trial overseen by CU Cancer Center member Chad Rusthoven, MD, and Vinai Gondi, MD, from Northwestern University, is testing whether a new treatment approach could result in improved outcomes for patients with small cell lung cancer (SCLC) that has spread to the brain. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 8, 2021 Category: Cancer & Oncology Source Type: news

Consumer Health: Treating pituitary tumors
The pituitary is a small, bean-shaped gland at the base of your brain, behind your nose and between your ears. Despite its small size, the pituitary gland influences nearly every part of your body. The hormones it produces help regulate important functions, such as growth, blood pressure and reproduction. Pituitary tumors are abnormal growths that [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 8, 2021 Category: Databases & Libraries Source Type: news

NIDCR's Spring 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Spring 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR & NIH Stand Against Structural Racism NIDCR Director Rena D’Souza, DDS, MS, PhD, said in a statement that there is no place for structural racism in biomedical research, echoing remarks from NIH Director Francis Collins, MD, PhD, in his announcement of a new NIH ...
Source: NIDCR Science News - April 7, 2021 Category: Dentistry Source Type: news

Paul Ritter, actor in 'Harry Potter' and 'Chernobyl,' dead at 54 after suffering brain tumor
Paul Ritter, known for the "Harry Potter" franchise and "Chernobyl" died at age 54. (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2021 Category: Consumer Health News Source Type: news

'Harry Potter' Actor Paul Ritter Dies of Brain Tumor at 54
'Harry Potter" actor Paul Ritter dead at 54. (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2021 Category: Consumer Health News Source Type: news

Vysioneer secures FDA clearance for brain tumor contouring software
The U.S. Food and Drug Administration (FDA) has cleared artificial intelligenc...Read more on AuntMinnie.comRelated Reading: Akesis radiation therapy system cleared Radformation releases rad therapy contouring software European Commission gives OK to big Siemens/Varian deal Hypofractionated radiotherapy helped England survive COVID-19 ViewRay posts mixed financial results for Q4, year (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news

Christ Hospital, Mayfield Brain & Spine announce new partnership
Two of the region ’s most recognized health care providers are partnering to enhance care for patients with brain tumors and other brain diseases. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 5, 2021 Category: Biotechnology Authors: Liz Engel Source Type: news

Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction
Amber Capone had become afraid of her husband. The “laid-back, bigger than life and cooler than cool” man she’d married had become isolated, disconnected and despondent during his 13 years as a U.S. Navy SEAL. Typically, he was gone 300 days of the year, but when he was home, Amber and their two children walked on eggshells around him. “Everyone was just playing nice until he left again,” Amber says. In 2013, Marcus retired from the military. But life as a civilian only made his depression, anger, headaches, anxiety, alcoholism, impulsivity and violent dreams worse. Sometimes he’d get up...
Source: TIME: Health - April 5, 2021 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized Drugs feature Magazine Mental Health Source Type: news

Assisted dying inquiry essential, leading brain surgeon says
A brain surgeon, left shocked and frightened by his cancer diagnosis, says the law needs changing. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 1, 2021 Category: Consumer Health News Source Type: news

Bisrat Debeb Models How Cancer Spreads to the Brain
From his student days in veterinary medicine in Ethiopia to running a lab on metastasis at MD Anderson Cancer Center, Debeb has a passion for understanding how living things work. (Source: The Scientist)
Source: The Scientist - April 1, 2021 Category: Science Tags: Scientist to Watch Magazine Issue Source Type: news

Potential new treatment strategy for breast cancer cells that have spread to the brain
(Massachusetts General Hospital) Access to fat is more limited in brain tissue than in other tissues in the body, and breast cancer cells that spread to the brain must increase their production of fatty acids, the building blocks of fat. In mice, blocking such cells' ability to synthesize fatty acids reduced breast tumor growth in the brain. The findings may be helpful for designing new treatments for patients whose cancer has spread to the brain. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2021 Category: Cancer & Oncology Source Type: news

Unique neurologic symptoms lead to surprising cancer diagnosis
A team of scientists from Mayo Clinic and two other institutions published a study in 2019 that showed the existence of an autoimmune disorder that affects men. The disorder causes the immune system to attack the brain, causing severe neurologic symptoms. That's what happened to a Florida man, and his search for answers led him [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 1, 2021 Category: Databases & Libraries Source Type: news

She Suffered Balance Issues for Years. Was It a Brain Tumor?
A visit to the dentist unexpectedly led to a resolution. (Source: NYT Health)
Source: NYT Health - March 31, 2021 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Ears and Hearing Vertigo Brain Tumors Source Type: news

Chemo for glioblastoma may work better in morning than evening
(Washington University School of Medicine) An aggressive type of brain cancer, glioblastoma has no cure. Patients survive an average of 15 months after diagnosis, with fewer than 10% of patients surviving longer than five years. While researchers are investigating potential new therapies via ongoing clinical trials, a new study from Washington University in St. Louis suggests that a minor adjustment to the current standard treatment -- giving chemotherapy in the morning rather than the evening -- could add a few months to patients' survival. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 31, 2021 Category: International Medicine & Public Health Source Type: news

Detecting cancer in the brain by scanning for salt
Yale scientists have devised a way to non-invasively locate tumors in the brain, by using an MRI scan to find where salt levels are imbalanced. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 30, 2021 Category: Universities & Medical Training Source Type: news

Microscopic Robots Deliver Drugs to the Brain
Researchers turned white blood cells called neutrophils into drug-smuggling "neutrobots," which penetrated the blood-brain barrier to treat brain cancer in mice. (Source: The Scientist)
Source: The Scientist - March 30, 2021 Category: Science Tags: News & Opinion Source Type: news

New AI-based versatile software for tracking many cells in 3D microscope videos
(Nagoya City University) The first deep-learning software was developed as a versatile tool for tracking cells and extracting their signals from ~100 cells in a moving worm brain, in a zebrafish heart, and ~1,000 cultured cancer cells in 3D microscope videos. The method demonstrates significant improvements in tracking capabilities on various metrics including the possible number of tracked objects, robustness, and computing requirements. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 30, 2021 Category: Biology Source Type: news

Upstate Cancer Center introduces multidisciplinary team for brain tumor patients
Program incorporates radiation oncology, neurosurgery and medical oncology. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - March 26, 2021 Category: Universities & Medical Training Tags: News Source Type: news

The Thursday Throng
‘Throng’ n. – A multitude of persons or of living beings pressing or pressed into a close body or assemblage; a crowd. This section of my website is called The Thursday Throng in honour of the throng that waits eagerly at the bookshop door when a new author book signing or speaking. It takes the form of a ‘Meet the Author’ online event with some information about our author’s latest book and an interview. Some authors also offered giveaways of their books and others have reviews I’ve written posted on Amazon (UK and US) and Goodreads. Past Thursday Throng Author Interviews 2018 ...
Source: The Hysterectomy Association - March 26, 2021 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Creativity author interview Source Type: news

Stressed brain linked to broken heart
(European Society of Cardiology) Heightened activity in the brain, caused by stressful events, is linked to the risk of developing a rare and sometimes fatal heart condition called Takotsubo syndrome (TTS), also known as " broken heart " syndrome, according to research published in the European Heart Journal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 25, 2021 Category: Cancer & Oncology Source Type: news

Decades of radiation-based scientific theory disproven by Ben-Gurion University US-based study
(American Associates, Ben-Gurion University of the Negev) According to the study, lower levels of several types of cancers were found when the radiation levels were on the higher end of the spectrum rather than on the lower end. Among both men and women, there was a significant decrease in lung, pancreatic, colon and rectal cancers. Among men, there were additional decreases in brain and bladder cancers. There was no decrease in cervix, breast or prostate cancers or leukemia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 24, 2021 Category: International Medicine & Public Health Source Type: news

Vaccination against mutated protein tested in brain tumor patients for the first time
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients' immune system to these mutated proteins. For the first time, physicians and cancer researchers from Heidelberg and Mannheim have now carried out a clinical trial to test a mutation-specific vaccine against malignant brain tumors. The vaccine proved to be safe and triggered the desired immune response in the tumor tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 24, 2021 Category: Cancer & Oncology Source Type: news

Massey researcher finds new strategy for fighting brain cancer
(Virginia Commonwealth University) Most people relate cholesterol to heart health, but it is also a critical component in the growth and spread of brain cancer. VCU Massey Cancer Center researcher Suyun Huang, Ph.D., recently discovered how cholesterol becomes dysregulated in brain cancer cells and showed that the gene responsible for it could be a target for future drugs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 23, 2021 Category: Cancer & Oncology Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Akesis brain disease imaging system cleared
Radiation therapy developer Akesis announced it has received 510(k) clearanc...Read more on AuntMinnie.comRelated Reading: Akesis taps new president Akesis gets FDA clearance for radiosurgery system RT improves elderly brain cancer patient survival Akesis launches new rad therapy systems at ASTRO 2019 Is thermal ablation effective for treating NSCLC? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 18, 2021 Category: Radiology Source Type: news

ATRT molecular groups: looking at the biology from the clinic
(St. Jude Children's Research Hospital) Scientists at St. Jude Children's Research Hospital are learning more about what the molecular groups of a rare pediatric brain tumor mean for clinical care. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 18, 2021 Category: Cancer & Oncology Source Type: news

Simple blood test could replace surgery for some brain tumour patients
(University of Plymouth) Researchers at the Brain Tumour Research Centre of Excellence at the University of Plymouth have discovered a biomarker which helps to distinguish whether meningioma - the most common form of adult primary brain tumour - is grade I or grade II. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 17, 2021 Category: Cancer & Oncology Source Type: news

Mother reveals how firstborn died of brain cancer within a year of birth
Amy Walsh, 28, from Bristol, revealed how her seven-month-old baby Rory died from brain cancer in January 2020. They welcomed son Finley in November last year. (Source: the Mail online | Health)
Source: the Mail online | Health - March 15, 2021 Category: Consumer Health News Source Type: news

Special Collection: Brain tumour diagnosis and management
Cochrane Library Special Collections provide a round-up of up-to-date Cochrane evidence on a specific topic.This Special Collection provides evidence in several key clinical priority areas for brain tumour research.  The reviews in this Collectionprovide evidence towards clinical priority areas for research, and their funding, and therefore, are important for consumers, clinicians, healthcare providers and funders.Topics include:Diagnosing brain tumours quickly, safely, and accuratelyRisk-sharing in decision making for brain tumoursBest treatment when decisions are difficult When asked about the new Special Colle...
Source: Cochrane News and Events - March 12, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Weight Gain Common in Childhood Brain Tumor Survivors Weight Gain Common in Childhood Brain Tumor Survivors
Children treated for brain tumors experienced significant weight gain and had a high rate of hypothalamic-pituitary dysfunction.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 12, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Five University of Colorado Cancer Center researchers receive grants to study brain tumors
(University of Colorado Anschutz Medical Campus) Three projects from University of Colorado Cancer Center researchers have received grants from the Denver-based Michele Plachy-Rubin Fund for Pilot Grants in Brain Cancer Research. Receiving $40,000 each to fund their work around brain cancer are Sujatha Venkataraman, PhD; and the teams of Philip Reigan, PhD, and Michael Graner, PhD; and Natalie Serkova, PhD, and Nicholas Foreman, MD, MBChB. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 10, 2021 Category: Cancer & Oncology Source Type: news

New spherical nucleic acid 'drug' kills tumor cells in humans with glioblastoma
(Northwestern University) An early clinical trial in individuals with the deadly brain cancer, glioblastoma, showed an experimental drug penetrated the blood-brain barrier and trigger the death of tumor cells. This is the first time a nanotherapeutic has been shown to cross the blood-brain barrier when given through intravenous infusion and alter the genetic machinery of a tumor to cause cell death. The drug dialed down the level of a cancer-causing gene and promoted tumor cell death. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 10, 2021 Category: Cancer & Oncology Source Type: news

Thoracic CT shows promise for monitoring health of obese patients
Thoracic CT shows promise as an imaging modality that could help clinician...Read more on AuntMinnie.comRelated Reading: CT-guided renal ablation is safe for treating cancer in obese patients Weight-loss surgery weakens teenagers' bones Use CTA to evaluate obese COVID-19 patients for PE risk DTI-MRI links obesity to areas of white-matter damage MRI shows obesity can influence brain volume (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 8, 2021 Category: Radiology Source Type: news

Immune cells in cerebrospinal fluid predict response to immunotherapy
(Vall d'Hebron Institute of Oncology) Immune cells accessing cerebrospinal fluid faithfully recapitulate the characteristics of cells identified in brain metastasis, and could therefore constitute novel biomarkers of response to immune-based therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 8, 2021 Category: Cancer & Oncology Source Type: news

What Are the Causes of Secondary Amenorrhea?
Discussion The first sign of puberty in females is breast budding (Tanner stage II) which normally occurs from 8-13 years. Menarche usually occurs within 2 years of breast budding occurring usually at Tanner stage III-IV breast development. Menarche occurs for most girls from 10-15 years. Most cycles range between 21-45 days. Age> 13 years without acquisition of secondary sexual characteristics,> 15 years before menarche or 5 years after acquisition of secondary sexual characteristics or cycles longer than 45 days are indications for evaluation. After menarche is it not uncommon to have anovulatory cycles that are ir...
Source: PediatricEducation.org - March 8, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Beyonc é Honors 13-Year-Old Fan Who Died Of Brain Cancer With Moving Medley
The singer performed a special version of "Love on Top" dedicated to her fan Lyric Chanel, who died on Friday after a two-year cancer battle. (Source: Reuters: Health)
Source: Reuters: Health - March 7, 2021 Category: Consumer Health News Source Type: news

Engineered 'off the shelf' stem cells target breast cancer that metastasizes to the brain
(Brigham and Women's Hospital) In a new study, researchers from Brigham and Women's Hospital and collaborators engineered a bimodal tumor-suppressing and killing molecule that can be delivered to the brain by stem cells. They tested the therapy in three new mouse models of BLBC-BM that imitate human cancers and found that it successfully prolonged the lifespan of the mice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 5, 2021 Category: Cancer & Oncology Source Type: news

The amazing promise of artificial intelligence in health care
(University of Virginia Health System) Artificial intelligence can already scan images of the eye to assess patients for diabetic retinopathy, a leading cause of vision loss, and to find evidence of strokes on brain CT scans. But what comes next? (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 5, 2021 Category: Cancer & Oncology Source Type: news

2nd window ICG predicts gross-total resection/progression-free survival in brain metastasis
(Journal of Neurosurgery Publishing Group) Researchers used delayed near-infrared imaging with high-dose indocyanine green (called " second window ICG " or " SWIG " ) in the identification of brain metastases during surgery. They found that SWIG can be used to predict the extent of gross-total resection and progression-free survival in these cases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 2, 2021 Category: Cancer & Oncology Source Type: news

New cancer scan could guide brain surgery
(Institute of Cancer Research) A type of ultrasound scan can detect cancer tissue left behind after a brain tumour is removed more sensitively than surgeons, and could improve the outcome from operations, a new study suggests. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 1, 2021 Category: Cancer & Oncology Source Type: news

Who Gets Pott ’ s Puffy Tumor?
Discussion Pott’s puffy tumor (PPT) was first described by Sir Percivall Pott in 1775 and who also described other orthopaedic and oncological diseases subsequently named for him. “It is a subperiosteal abscess of the anterior wall of the frontal sinus associated with underlying frontal osteomyelitis.” The tender edema and swelling of the forehead is the sign of PPT. Associated fever, headache, and rhinorrhea along with similar problems such as postnasal drip or nasal congestion are common. Associated ophthalmological problems include peri-orbital or eyelid edema and/or preseptal cellulitis. Ptosis and di...
Source: PediatricEducation.org - March 1, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Targeted delivery of highly toxic anti-cancer drug to brain tumors
(University of Houston) University of Houston biomedical researcher Sheeren Majd is reporting the development and testing of a new nano-carrier as a potential treatment to deliver highly toxic medicine to glioblastomas, the most common and aggressive form of primary brain tumors. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 23, 2021 Category: Biology Source Type: news

Stroke of luck: Scientists discover target for stroke therapy in blood-brain barrier
(Tokyo University of Science) The blood-brain barrier prevents immune cells from circulating freely in the brain, and the breakdown of its function is a major cause of post-stroke inflammation. Now, for the first time, researchers have identified how a toxic stroke byproduct, acrolein, could activate the barrier-degrading enzyme proheparanase (proHPSE). The research group has discovered that proHPSE degrades the glycocalyx within the post-stroke brain's blood vessels, providing hope for new and effective therapeutics against post-stroke inflammation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 22, 2021 Category: Cancer & Oncology Source Type: news

3D biopsies to better understand brain tumors
(Universitat Autonoma de Barcelona) Researchers at the Institut de Neuroci è ncies of the Universitat Aut ò noma de Barcelona (INc-UAB) obtained a highly accurate recreation of human glioblastoma's features using a novel 3D microscopy analysis. The study, published in the journal Acta Neuropathologica Communications, provides new information to help with the diagnose, by finding therapeutical targets and designing immunotherapeutical strategies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 19, 2021 Category: Cancer & Oncology Source Type: news

Dr. Frederick Boop presents at the ISPN 2020 Virtual Meeting
(Le Bonheur Children's Hospital) Understanding the molecular biology of brain tumors is key to prognosis and treatment said Le Bonheur Neuroscience Institute Co-Director Frederick Boop, MD, in his presentation " How Molecular Biology Impacts Clinical Practice " at the International Society for Pediatric Neurosurgery (ISPN) 2020 Virtual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 17, 2021 Category: International Medicine & Public Health Source Type: news

Combination treatment for common glioma type shows promise in mice
NIH-funded preclinical study suggests new approach to treat a type of brain tumor (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 16, 2021 Category: American Health Source Type: news

Combination treatment for common glioma type shows promise in mice
(NIH/National Institute of Neurological Disorders and Stroke) Gliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study funded by the National Institutes of Health (NIH), researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas and found tumor regression in 60 percent of the mice treated. These encouraging results could be the first step toward developing a treatment for this type of brain cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2021 Category: Cancer & Oncology Source Type: news